Key result
Alcoholic cardiomyopathy mortality matches nonalcoholic DCM, and alcohol abstinence fails to improve survival.
Why the study?
Does abstinence from alcohol improve survival, and what are the risk factors for mortality in male patients with alcoholic cardiomyopathy compared to nonalcoholic dilated cardiomyopathy?
Cohort (n=169)
Does abstinence from alcohol improve survival, and what are the risk factors for mortality in male patients with alcoholic cardiomyopathy compared to nonalcoholic dilated cardiomyopathy?
In male patients with alcoholic cardiomyopathy, survival is similar to those with nonalcoholic dilated cardiomyopathy and is primarily driven by echocardiographic parameters (LVDD, IMLC) rather than alcohol abstinence.
Although a relationship has been suggested between abstinence from alcohol and improvement in left ventricular (LV) function, no long-term studies in large groups of patients have been done to confirm this impression or to demonstrate an effect on survival. To address these questions, the authors analyzed the outcome in 105 male patients with alcoholic cardiomyopathy and 64 control male patients with nonalcoholic dilated cardiomyopathy. Survival data were available for all patients. The correlates of survival were assessed via the Cox proportional hazards model. Variables considered were age, race, drinking pattern (current drinker versus former drinker), presence of coronary artery disease (CAD), hypertension, and diabetes, and these echo variables: left atrial (LA) size, posterior wall thickness, LV end diastolic dimension (LVDD), minimal E point septal separation, wall motion, presence of incomplete mitral leaflet closure (IMLC) or low cardiac output, and the ratio of relative wall thickness to LVDD. The two study groups were comparable with respect to all echocardiographic variables. At a mean follow-up of 17.2 months +/- 12.1 months, 42.85% of the alcoholics and 41% of the nonalcoholics had died. Nonsurvival in the alcoholic group was significantly associated with only two factors: an increased LVDD and the presence of IMLC. The drinking pattern was not significantly associated with survival. By contrast, in the nonalcoholics,the variables most closely related to survival were LVDD, low cardiac output, increasing age, and abnormal wall motion. Therefore: (1) the risk factors in alcoholic and nonalcoholic cardiomyopathy are similar although IMLC appears to be a relatively specific prognostic factor for alcoholic cardiomyopathy and (2) abstinence from alcohol does not appear to improve survival.
No takes yet. Share an insight, caveat, or question.
Kinney et al. (1989) conducted a cohort in Alcoholic cardiomyopathy (n=169). Alcoholic cardiomyopathy vs. Nonalcoholic dilated cardiomyopathy was evaluated on Mortality. Alcoholic cardiomyopathy was associated with a 42.85% mortality rate at 17.2 months, similar to the 41% mortality in nonalcoholic dilated cardiomyopathy, and abstinence did not improve survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: